Jfs Wealth Advisors, LLC Grifols Sa Transaction History

Jfs Wealth Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$5.96 - $8.53 $45,576 - $65,228	-7,647 Reduced 97.49%	197 $1,000
Q3 2022 Oct 21, 2022	SELL	$5.95 - $14.3 $9,769 - $23,480	-1,642 Reduced 17.31%	7,844 $48,000
Q2 2022 Aug 02, 2022	SELL	$10.6 - $13.28 $731 - $916	-69 Reduced 0.72%	9,486 $113,000
Q1 2022 May 02, 2022	SELL	$10.37 - $12.73 $14,466 - $17,758	-1,395 Reduced 12.74%	9,555 $112,000
Q4 2021 Feb 03, 2022	BUY	$10.21 - $15.27 $21,144 - $31,624	2,071 Added 23.32%	10,950 $123,000
Q3 2021 Nov 09, 2021	BUY	$14.07 - $17.3 $17,348 - $21,330	1,233 Added 16.13%	8,879 $130,000
Q2 2021 Aug 04, 2021	BUY	$16.62 - $18.94 $18,763 - $21,383	1,129 Added 17.32%	7,646 $133,000
Q1 2021 Apr 28, 2021	BUY	$15.15 - $19.78 $47,980 - $62,643	3,167 Added 94.54%	6,517 $113,000
Q4 2020 Feb 01, 2021	BUY	$16.86 - $19.67 $56,481 - $65,894	3,350 New	3,350 $62,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.31B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Jfs Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Jfs Wealth Advisors, LLC with notifications on news.